EICHORPublic-registry site landscape for NCT03955211, “HTX-011 Administration Study in Planned Caesarean Section Procedure”, a Analgesia study sponsored by Heron Therapeutics. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03955211 (registry record) |
| Study title | HTX-011 Administration Study in Planned Caesarean Section Procedure |
| Official title | A Phase 2 Open-Label Study of the Pharmacokinetics (PK) and Safety of HTX-011 Administered Postpartum to Women Undergoing a Planned Caesarean Section |
| Sponsor | Heron Therapeutics |
| Condition(s) | Analgesia |
| Phase | PHASE2 |
| Listed sites | 4 |
| Intervention(s) | HTX-011, Ibuprofen, Acetaminophen |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT03955211.
Eichor generates a preliminary site-risk snapshot for NCT03955211 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
